Home
Mail
News
Finance
Sports
Entertainment
Search
Mobile
More...
Yahoo Finance
Search
Skip to Navigation
Skip to Main Content
Skip to Related Content
Sign in
Mail
Sign in
to view your mail
Finance Home
Watchlists
My Portfolio
Markets
News
Videos
Yahoo Finance Plus
Screeners
Personal Finance
Crypto
Industries
Contact Us
Advertisement
Advertisement
U.S. markets closed
S&P Futures
4,253.00
-11.75
(-0.28%)
Dow Futures
33,122.00
-79.00
(-0.24%)
Nasdaq Futures
14,678.75
-35.75
(-0.24%)
Russell 2000 Futures
1,735.40
-6.50
(-0.37%)
Crude Oil
89.24
+0.01
(+0.01%)
Gold
1,838.00
-3.50
(-0.19%)
Advertisement
Advertisement
Advertisement
Advertisement
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SS)
Shanghai - Shanghai Delayed Price. Currency in CNY
Follow
47.98
-1.10
(-2.24%)
At close: 03:00PM CST
Advertisement
Summary
Company Insights
Chart
Conversations
Statistics
Historical Data
Profile
Financials
Analysis
Options
Holders
Sustainability
Advertisement
Show
:
Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly
Subscribe to Yahoo Finance Plus Essential to download historical data
Download
Income Statement
Expand All
All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Learn more
Breakdown
ttm
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
9,419,102
11,185,189
5,750,329
2,354,257
1,183,754
Cost of Revenue
936,078
1,170,412
817,711
442,142
330,864
Gross Profit
8,483,025
10,014,777
4,932,618
1,912,115
852,890
Operating Expense
4,304,628
4,415,195
2,496,240
1,086,379
631,596
Operating Income
4,178,397
5,599,582
2,436,378
825,737
221,294
Net Non Operating Interest Income Expense
66,311
33,725
3,550
2,919
7,188
Pretax Income
4,261,639
5,582,691
2,324,145
764,452
216,808
Tax Provision
468,241
719,390
244,931
82,636
6,506
Net Income Common Stockholders
3,745,212
4,735,795
2,021,468
676,997
208,864
Basic EPS
-
3.79
1.64
0.57
0.19
Diluted EPS
-
3.79
1.64
0.57
0.19
Basic Average Shares
-
1,248,609
1,230,459
1,195,047
1,099,245
Diluted Average Shares
-
1,248,609
1,230,459
1,195,047
1,099,245
Total Operating Income as Reported
4,274,822
5,596,038
2,328,456
775,203
218,330
Total Expenses
5,240,705
5,585,607
3,313,951
1,528,520
962,461
Net Income from Continuing & Discontinued Operation
3,745,212
4,735,795
2,021,468
676,997
208,864
Normalized Income
3,792,142
4,820,633
2,122,199
722,701
232,351
Interest Income
74,266
42,151
9,772
4,976
8,570
Interest Expense
6,820
7,670
5,691
1,686
1,041
Net Interest Income
66,311
33,725
3,550
2,919
7,188
EBIT
4,268,459
5,590,361
2,329,836
766,137
217,849
EBITDA
4,463,455
5,742,261
2,435,112
850,605
298,357
Reconciled Cost of Revenue
936,078
1,170,412
817,711
442,142
330,864
Reconciled Depreciation
194,996
151,900
105,276
84,468
80,508
Net Income from Continuing Operation Net Minority Interest
3,745,212
4,735,795
2,021,468
676,997
208,864
Total Unusual Items Excluding Goodwill
-52,723
-97,387
-112,597
-51,243
-24,213
Total Unusual Items
-52,723
-97,387
-112,597
-51,243
-24,213
Normalized EBITDA
4,516,178
5,839,648
2,547,709
901,849
322,570
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-5,793
-12,549
-11,866
-5,539
-726.6359
Yahoo Finance Plus Essential access required.
Learn more
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2023 Yahoo. All rights reserved.
Data Disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Your Privacy Choices
About Our Ads
Sitemap